Membranous CD44v6 is upregulated as an early event in colorectal cancer: Downregulation is associated with circulating tumor cells and poor prognosis

Previous studies have reported that CD44 variant 6 (CD44v6) and metastasis-associated protein 1 (MTA1) are contributing factors to cancer progression. The present study aimed to evaluate the expression profiles for associations with patients' demographic data, clinicopathological characteristic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataki, Agapi, Giannakoulis, Vassilis G., Derventzi, Anastasia, Papiris, Konstantinos, Koniaris, Eythimios, Konstadoulakis, Manousos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527563/
https://www.ncbi.nlm.nih.gov/pubmed/34691247
http://dx.doi.org/10.3892/ol.2021.13081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527563/
https://www.ncbi.nlm.nih.gov/pubmed/34691247
http://dx.doi.org/10.3892/ol.2021.13081

Ejemplares similares